The Outcome of Tisagenlecleucel (Tisa-Cel) CD-19 CAR-T Cell Therapy in NHL Relapsed/Refractory Beyond Second Line of Therapy, Single-Center Data
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
ABCL, lymphoma, DLBCL, CAR-T, tisagenlecleucel, CRS
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要